Low dose rivaroxaban for secondary prophylaxis after full anticoagulation in patients with venous thromboembolism

被引：0
|
作者：
Zhou, A. [1 ]
Chan, A. K. [2 ]
Lau, K. K. [3 ]
Chan, H. H. [4 ]
机构：
[1] McMaster Univ, Honours Integrated Sci Program, Hamilton, ON, Canada
[2] McMaster Univ, Pediat, Hamilton, ON, Canada
[3] Univ Hong Kong, Shenzhen Hosp, Pediat, Shenzhen, Peoples R China
[4] McMaster Univ, Med, Hamilton, ON, Canada
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO359-TUE
引用
收藏
页码：637 / 638
页数：2
相关论文
共 50 条
  • [31] Venous thromboembolism prophylaxis with rivaroxaban in elective foot and ankle surgery
    Wiewiorski, Martin
    Barg, Alexej
    Hugle, Thomas
    Valderrabano, Victor
    SWISS MEDICAL WEEKLY, 2017, 147 : 60S - 60S
  • [32] "Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Reply
    Larsen, Trine-Lise
    Garresori, Herish
    Brekke, Jorunn
    Enden, Tone
    Froen, Hege
    Jacobsen, Eva Marie
    Quist-Paulsen, Petter
    Porojnicu, Alina Carmen
    Ree, Anne Hansen
    Torfoss, Dag
    Velle, Elin Osvik
    Wik, Hilde Skuterud
    Ghanima, Waleed
    Sandset, Per Morten
    Dahm, Anders Erik Astrup
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (08) : 1937 - 1939
  • [33] Anticoagulation in Venous Thromboembolism Prophylaxis in Medically Ill Patients: Potential Impact of NOACs
    Knotts, Tara L.
    Mousa, Shaker A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (04) : 365 - 376
  • [34] Anticoagulation in Venous Thromboembolism Prophylaxis in Medically Ill Patients: Potential Impact of NOACs
    Tara L. Knotts
    Shaker A. Mousa
    American Journal of Cardiovascular Drugs, 2019, 19 : 365 - 376
  • [35] Extended anticoagulation after venous thromboembolism
    Laursen, Rasmus
    Sondergaard, Hanne M.
    Bording, Pia
    Svenstrup, Dorthe
    DANISH MEDICAL JOURNAL, 2024, 71 (10):
  • [36] Fatigue after initiating rivaroxaban for venous thromboembolism
    Karlsvik, Tina Margrethe
    Borgenvik, Thore Langfeldt
    Aadalen, Mirjam
    Utne, Kristin
    Forsund, Eli
    Jorgensen, Camilla Tovik
    Holst, Rene
    Jelsness-Jorgensen, Lars-Petter
    Ghanima, Waleed
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 582 - 585
  • [37] No need for a rivaroxaban dose reduction in renally impaired patients with symptomatic venous thromboembolism
    Bauersachs, R.
    Lensing, A. W. A.
    Pap, A.
    Decousus, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 30 - 31
  • [38] Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up
    Lagana, Alessandro
    Assanto, Giovanni Manfredi
    Masucci, Chiara
    Passucci, Mauro
    Donzelli, Livia
    Serrao, Alessandra
    Baldacci, Erminia
    Santoro, Cristina
    Chistolini, Antonio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [39] Anticoagulation: Venous Thromboembolism in Patients with Cancer
    Andrade, Priya
    Fausto, James
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 41 (01) : 274 - 275
  • [40] Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
    Bott-Kitslaar, Dalene M.
    McBane, Robert D.
    Casanegra, Ana I.
    Houghton, Damon E.
    Froehling, David A.
    Vlazny, Danielle T.
    Ashrani, Aneel A.
    Hodge, David O.
    Vargas, Emily R.
    Bartlett, Matthew A.
    Saadiq, Rayya A.
    Daniels, Paul R.
    Shields, Raymond C.
    Lenz, Charles J.
    Lang, Teresa R.
    Wysokinski, Waldemar E.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1242 - 1252
12345